Follow-The-Filings

Security · featured owners

RCUS Arcus Biosciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 2.6%
  • $14M
  • 1 reduce

RCUS (Arcus Biosciences Inc.) is held in 1 featured 13F book as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (2.6%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.6% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel reduce 2.6%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 2.6% Reduce −0.5% 441,829 $14M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Aug 21, 2026 Filing Doc
4 Period Jul 9, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 11, 2026 · 8 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 11, 2026 Filing Doc
4 Period Dec 16, 2025 Filing Doc
4 Period Jan 23, 2026 · 7 forms Filing Doc
4 Period Jan 8, 2026 Filing Doc
4 Period Jan 5, 2026 Filing Doc
4 Period Dec 30, 2025 Filing Doc
4 Period Dec 31, 2025 Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $117M $51M $33M
Net income -$307M -$283M -$353M
Net margin * -262.4% -554.9% -1069.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.831B $1.02B $1.01B
Total non-current assets * $264M $134M $132M
Total assets $1.1B $1.15B $1.14B
Total current liabilities $184M $226M $231M
Total equity $462M $485M $631M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$306M -$170M -$482M
Cash from investing $194M -$84M $66M
Cash from financing $33M $277M $488M
Net change in cash -$79M $23M $72M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders